SPDYE8
gene geneOn this page
Summary
SPDYE8 (speedy/RINGO cell cycle regulator family member E8, HGNC:33771) is a protein-coding gene on chromosome 7q11.23, encoding Speedy protein E8 (P0DUD1).
Enables acetylcholine receptor regulator activity.
Source: NCBI Gene 728524 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001382525
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33771 |
| Approved symbol | SPDYE8 |
| Name | speedy/RINGO cell cycle regulator family member E8 |
| Location | 7q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000273520 |
| Ensembl biotype | protein_coding |
| Entrez | 728524 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000333385
RefSeq mRNA: 2 — MANE Select: NM_001382525
NM_001382525, NM_001422015
CCDS: CCDS94114
Canonical transcript exons
ENST00000333385 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002432238 | 73029645 | 73029766 |
| ENSE00002445114 | 73027837 | 73028419 |
| ENSE00003711758 | 73022054 | 73022158 |
| ENSE00003735145 | 73025543 | 73025601 |
| ENSE00003843385 | 73022281 | 73022524 |
| ENSE00003846053 | 73024230 | 73024315 |
| ENSE00003847665 | 73026635 | 73026853 |
| ENSE00003924683 | 73019719 | 73021200 |
Expression profiles
Bgee: expression breadth broad, 12 present calls, max score 53.89.
Top tissues by expression
100 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| stromal cell of endometrium | CL:0002255 | 53.89 | gold quality |
| cortical plate | UBERON:0005343 | 48.37 | gold quality |
| colonic epithelium | UBERON:0000397 | 46.84 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 46.60 | silver quality |
| placenta | UBERON:0001987 | 43.57 | gold quality |
| prefrontal cortex | UBERON:0000451 | 42.78 | silver quality |
| bone marrow | UBERON:0002371 | 41.89 | gold quality |
| muscle tissue | UBERON:0002385 | 40.94 | gold quality |
| bone marrow cell | CL:0002092 | 40.24 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 40.05 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 38.66 | gold quality |
| cortex of kidney | UBERON:0001225 | 38.54 | silver quality |
| adrenal tissue | UBERON:0018303 | 38.51 | gold quality |
| granulocyte | CL:0000094 | 37.55 | gold quality |
| kidney | UBERON:0002113 | 35.94 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 35.90 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.69 | gold quality |
| cerebellum | UBERON:0002037 | 35.56 | gold quality |
| apex of heart | UBERON:0002098 | 35.48 | gold quality |
| fallopian tube | UBERON:0003889 | 35.48 | gold quality |
| blood | UBERON:0000178 | 35.41 | gold quality |
| monocyte | CL:0000576 | 35.31 | gold quality |
| sural nerve | UBERON:0015488 | 35.29 | gold quality |
| cerebellar cortex | UBERON:0002129 | 35.27 | gold quality |
| leukocyte | CL:0000738 | 35.21 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 34.94 | gold quality |
| mucosa of stomach | UBERON:0001199 | 34.85 | gold quality |
| left uterine tube | UBERON:0001303 | 34.74 | silver quality |
| corpus callosum | UBERON:0002336 | 33.86 | gold quality |
| muscle of leg | UBERON:0001383 | 33.80 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spdye4b | ENSMUSG00000029586 |
| mus_musculus | Spdye4a | ENSMUSG00000039296 |
| rattus_norvegicus | Spdye4 | ENSRNOG00000058563 |
Paralogs (18): SPDYE1 (ENSG00000136206), SPDYE5 (ENSG00000170092), SPDYE2B (ENSG00000173678), SPDYE4 (ENSG00000183318), SPDYE12 (ENSG00000184616), SPDYE16 (ENSG00000185040), SPDYE17 (ENSG00000186645), SPDYE2 (ENSG00000205238), SPDYE18 (ENSG00000205482), SPDYE3 (ENSG00000214300), SPDYE21 (ENSG00000230358), SPDYE6 (ENSG00000260097), SPDYE9 (ENSG00000262461), SPDYE10 (ENSG00000274570), SPDYE11 (ENSG00000275976), SPDYE15 (ENSG00000286014), SPDYE13 (ENSG00000286038), SPDYE14 (ENSG00000286137)
Protein
Protein identifiers
Speedy protein E8 — P0DUD1 (reviewed: P0DUD1)
All UniProt accessions (1): P0DUD1
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the Speedy/Ringo family.
RefSeq proteins (2): NP_001369454, NP_001408944 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR020984 | Speedy | Family |
| IPR057742 | Speedy_E | Family |
Pfam: PF11357
UniProt features (3 total): chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DUD1-F1 | 70.40 | 0.42 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 3 (showing top):
chr7q11, GOMF_KINASE_BINDING, MCCABE_BOUND_BY_HOXC6
GO Biological Process (1): positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)
GO Molecular Function (1): protein kinase binding (GO:0019901)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of cyclin-dependent protein serine/threonine kinase activity | 1 |
| cyclin-dependent protein serine/threonine kinase activity | 1 |
| positive regulation of cell cycle | 1 |
| positive regulation of protein serine/threonine kinase activity | 1 |
| positive regulation of cyclin-dependent protein kinase activity | 1 |
| kinase binding | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0J9YY54, A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NNV3, B4DH59, F6SZT2, P0C6Y7, P0CI01, P0DKJ7, P0DKJ8, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, P79386, Q08AG5, Q13342, Q16666, Q3BBV2, Q495Y8, Q587J8, Q5JRC9, Q5QGU6, Q5RD14, Q5RKG3, Q63HK3, Q6ITT4, Q7TQI8, Q86T75, Q8IWY8, Q8N660, Q8NFV5
Diamond homologs: A0A494C086, A0A494C0Z2, A0A494C191, A6NHP3, A6NIY4, A6NJR5, A6NKU9, A6NLX3, A6NNV3, P0CI01, P0DTA3, P0DUD1, P0DUD2, P0DUD3, P0DUD4, P0DUX0, P0DUX1, P0DV79, Q495Y7, Q495Y8, Q5IBH6, Q5IBH7, Q5MJ68, Q5MJ70, Q8NFV5, Q8R496, Q9PU13, Q9YGL1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS112179766 (7:73023576 T>A), RS1174598588 (7:73027456 C>T), RS1176834952 (7:73027468 CTTTTTTTTTTTTTTT>C,CTT,CTTT,CTTTTTTT,CTTTTTTTT,CTTTTTTTTTTTTT,CTTTTTTTTTTTTTT,CTTTTTTTTTTTTTTTT), RS1203833240 (7:73026876 C>T), RS1206588594 (7:73027502 T>C), RS1211267149 (7:73027744 G>A), RS1216245338 (7:73027120 G>T), RS1222826543 (7:73027772 C>T), RS1234610275 (7:73027143 G>T), RS1273713002 (7:73027099 T>C), RS1277269167 (7:73027265 C>T), RS1279372751 (7:73027682 T>A), RS1280743919 (7:73027870 C>G), RS1302375855 (7:73027138 G>T), RS1304490010 (7:73027758 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Cadmium | decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Gasoline | affects cotreatment, decreases expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Polycyclic Aromatic Hydrocarbons | affects cotreatment, decreases expression, increases abundance | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | increases methylation | 1 |
| Tretinoin | increases expression | 1 |
| 1-Butanol | affects cotreatment, decreases expression, increases abundance | 1 |
| Particulate Matter | affects cotreatment, decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.